Tag Archives: Bayer

AN UPDATE: India – Natco – Compulsory license

This is an update of Natco’s compulsory license application for Sorafenib and continuation of the earlier post. Controller of patent posted this CL opposition hearing on Jan 06, 2012. (DNA article). Bayer/patentee has sought for adjournment of this hearing (copy of … Continue reading

Posted in Daily interesting IP news, Patent case | Tagged , , , | Leave a comment

Bayer Vs Controller of patents

[SpicyIP] [Order] Yesterday, a interesting news is posted in SpicyIP blog.  Bayer challenges ambiguity in statutory language of “prima facie case” of section 87(1). Controller has published Natco’s compulsory license as per section 87(1) as prima facie case made out (published on Aug 12th … Continue reading

Posted in Daily interesting IP news, Patent case | Tagged , , , | 1 Comment

Breach of agreement-Onyx Vs Bayer-Sorafenib derivative

This is about breach of contract/collaborative agreement between onyx and bayer. [Press release] Recently Onyx and Bayer announced settlement agreement regarding the drug called “Regorafenib”(BAY73-4506). Regorafenib is structurally similar to sorafenib except a Fluoro substitution on sorafenib moiety. Sorafenib Regorafenib … Continue reading

Posted in Drug developments & targets | Tagged , , , | Leave a comment

Yasmin patent revoked in Europe

[Fox business] EPO revokes EP1214076B1 patent relates to Formulation of Yasmin product and it is equivalent of US6787531 (Not updated in register Plus). This decision came from appeal filed by Hexal against Opposition board decision. The same patent’s equivalent (IN/PCT/2002/410/CHE) … Continue reading

Posted in Patent case | Tagged , , , | Leave a comment

Bayer-Anti-TNF antibodies patent- J&J and Abbott drugs (US & Europe)

Bayer had sued Abbott and J&J for their Anti-TNF antibody drugs Adalimumab (Humira) and Golimumab (Simponi) respectively on Dec 2008 and Aug 2009. The patent involved in these suit, was US5654407 covers Human monoclonal antibodies composition. According to Bloomberg article, Bayer has terminated both the … Continue reading

Posted in Patent case | Tagged , , , , , , | Leave a comment

Zydus and Bayer forms Joint Venture in india

[Bayer Press Release] [Cadila Press Release] Bayer and Zydus cadila yesterday announced and signed to form Joint venture in India named Bayer Zydus Pharma. Bayer Zydus Pharma will operate in key segments of the Indian pharma market with a focus on: … Continue reading

Posted in Daily interesting IP news | Tagged , , , , | 1 Comment